Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy?

Teprotumumab showed promising efficacy in the treatment of PTD. Further studies are needed to confirm its durability and safety.

Authors

Institutions

Publication Details

Journal
Thyroid
Published
2026-01-13
DOI
https://doi.org/10.1177/10507256251414948
Primary Topic
Ophthalmology and Eye Disorders
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy?

Dana Hamadi, Suhail Saad-Omer, Marius N. Stan, David Toro-Tobon
Thyroid
Ophthalmology and Eye Disorders
article

Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy?

Dana Hamadi, Suhail Saad-Omer, Marius N. Stan, David Toro-Tobon
article en

Abstract

Teprotumumab showed promising efficacy in the treatment of PTD. Further studies are needed to confirm its durability and safety.

ThyroidVol. 36(2)
Mayo Clinic in Arizona (US), Hennepin Healthcare Research Institute (US)
Good health and well-being
Openalex Percentile: Top 89%
Ophthalmology and Eye Disorders
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Beyond the Eyes: Is Teprotumumab Effective for Thyroid Dermopathy? — Dana Hamadi, Suhail Saad-Omer, et al. · Thyroid (2026) | TGRS Research Map | TGRS